← Open Payments lookup

TAMSIN BLANCHARD: Open Payments

NPI 1700240835 · SEBASTIAN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$978 in 29 payments from 12 companies in 2025. Trend: 2023 $1,178 · 2024 $404 · 2025 $978

Food & beverage: $961Education: $17
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$334
Grifols USA, LLC3$147
Lilly USA, LLC1$124
GlaxoSmithKline, LLC.4$87
Insmed, Inc.3$73
Pulmonx Corporation2$60
Boehringer Ingelheim Pharmaceuticals, Inc.2$41
Electromed, Inc.3$28
GENZYME CORPORATION1$27
Merck Sharp & Dohme LLC1$26

Products named: Prolastin-C Liquid, FASENRA, BREZTRI, MOUNJARO, CHARTIS CATHETER, NUCALA, Arikayce, TEZSPIRE.

Industry payments across FL — which companies pay providers there.